Alpha Tau Medical Competitors and Similar CompaniesClear all

Alpha Tau Medical's competitors and similar companies include Coherus Oncology, Foghorn Therapeutics, Neovii and ImmPACT-Bio.

	Alpha Tau Medical Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.	Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.	Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.	ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
Founding Date	Founding Date 2016	Founding Date 2010	Founding Date 2016	Founding Date 2003	Founding Date 2017
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Tel Aviv-Yafo, IL HQ Boston, US	Locations Redwood City, US HQ Camarillo, US	Locations Cambridge, US HQ Cambridge, US	Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US	Locations Camarillo, US HQ Rishon Le Tsiyon, IL
Employees	Employees 1041% increase	Employees 14736% decrease	Employees 1123% decrease	Employees 1193% increase	Employees 845% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 85.6 m	Valuation ($) 452 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $42.2m (FY, 2025)	Revenue (est.) $30.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income $168m (FY, 2025)	Net income ($74.4m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 26m (about 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 18m (almost 6 years ago)
Total funding raised	Total funding raised $ 55m	Total funding raised $ 174.5m	Total funding raised $ 50m	Total funding raised N/A	Total funding raised $ 18m